Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
British Journal of Cancer|January 1, 1997
E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesisC B Vos, A M Cleton-Jansen, G Berx, et al.
The Journal of Pathology|August 23, 2008
Refinement of breast cancer classification by molecular characterization of histological special typesB Weigelt, H M Horlings, B Kreike, et al.
Cancer|June 22, 2000
Lymphatic mapping with intralesional tracer administration in breast carcinoma patientsM H Doting, L Jansen, O E Nieweg, et al.
Cancer Research|August 1, 1994
Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutationsR S Cornelis, M van Vliet, C B Vos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2002
Randomized trial of high-dose chemotherapy and hematopoietic progenitor-cell support in operable breast cancer with extensive lymph node involvement: final analysis with 7 years of follow-upJ G Schrama, I F Faneyte, J H Schornagel, et al.
Lancet (London, England)|August 26, 1998
Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvementS Rodenhuis, D J Richel, E van der Wall, et al.
European Journal of Cancer (Oxford, England : 1990)|February 16, 2000
Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer. Dutch Study Group on local Recurrence after Breast Conservation (BORST)A C Voogd, J L Peterse, M A Crommelin, et al.
European Journal of Cancer (Oxford, England : 1990)|October 3, 2003
Interobserver variability between general and expert pathologists during the histopathological assessment of large-core needle and open biopsies of non-palpable breast lesionsH M Verkooijen, J L Peterse, M E I Schipper, et al.
European Journal of Cancer (Oxford, England : 1990)|April 22, 1999
Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative GroupG van Tienhoven, A C Voogd, J L Peterse, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 1, 1997
Prognostic value of DNA ploidy using flow cytometry in 1301 breast cancer patients: results of the prospective Multicenter Morphometric Mammary Carcinoma ProjectE Bergers, J P Baak, P J van Diest, et al.
Pageof 11